BiotechTube

Clocortolone Pivalate

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Bioequivalence Study

Conditions

Bioequivalence Study

Trial Timeline

Mar 2, 2018 → May 11, 2018

NCT ID
NCT04358770

About Clocortolone Pivalate

Clocortolone Pivalate is a phase 1 stage product being developed by Sun Pharmaceutical for Bioequivalence Study. The current trial status is completed. This product is registered under clinical trial identifier NCT04358770. Target conditions include Bioequivalence Study.

What happened to similar drugs?

1 of 1 similar drugs in Bioequivalence Study were approved

Approved (1) Terminated (0) Active (0)
✅amoxicillinGSK plcApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT04358770Phase 1Completed

Competing Products

20 competing products in Bioequivalence Study

See all competitors
ProductCompanyStageHype Score
Bupropion HCl MR tablets 300mgAlembic PharmaceuticalsPhase 1
29
Fingolimod 0.5 mg capsules- Test drugAlembic PharmaceuticalsPhase 1
29
Lamotrigine ER tablet 50mgAlembic PharmaceuticalsPhase 1
29
Sonelokimab + SonelokimabMoonLake ImmunotherapeuticsPhase 1
23
GP30101 + Prezista® + GP30101 + Prezista®GEROPHARMPre-clinical
16
Metformin + Glucophage® + Metformin + Glucophage®GEROPHARMPhase 1
19
Metformine + Glucophage® Long + Metformin + Glucophage® LongGEROPHARMPhase 1
19
Humulin® Regular + Rinsulin® RGEROPHARMPre-clinical
16
Bosentan 125 mg + Tracleer 125Mg TabletGEROPHARMPhase 1
19
Rinsulin® mix 30/70 + Humulin® M3GEROPHARMPre-clinical
16
Memantinol tablets, 20 mg + Akatinol Memantine® tablets, 20 mgGEROPHARMPhase 1
19
Oxymetazoline hydrochloride Cream, 1% + Rhofade™ (oxymetazoline) cream, 1% + PlaceboSun PharmaceuticalPhase 1
29
Tablet paracetamol, guaifenesin and phenylephrine HCL + Vicks Active SymptoMax Plus powder for oral solutionJohnson & JohnsonPhase 1
29
SHR-1314Jiangsu Hengrui MedicinePhase 1
25
Onglyza (saxagliptin) + Diabex + 5-mg saxagliptin/1000 mg metformin + Diabex + 5-mg saxagliptin/500 mg metforminAstraZenecaPhase 1
29
selumetinib 75mg single dose + selumetinib 75mg single dose + selumetinib 75mg single doseAstraZenecaPhase 1
29
OmeprazoleAstraZenecaPhase 1
29
dapagliflozin/metformin XR 5/500 mg test drug (Mount Vernon) + dapagliflozin/metformin XR 5/500 mg reference drug (Humacao) + dapagliflozin/metformin XR 10/1000 mg test drug (Mount Vernon) + dapagliflozin/metformin XR 10/1000 mg reference drug (Humacao)AstraZenecaPhase 1
29
D961S + Esomeprazole + Buffered acetylsalicylic acidAstraZenecaPhase 1
29
Treatment A: Acalabrutinib tablet + Treatment B: Acalabrutinib capsuleAstraZenecaPhase 1
29